Pharmacogenomic testing: knowing more, doing better
- PMID: 22343816
- DOI: 10.1038/clpt.2011.339
Pharmacogenomic testing: knowing more, doing better
Abstract
The clinical uptake of pharmacogenomic (PGx) testing and genotype-based prescribing has been disappointingly slow even though research on PGx is thriving. A recent survey on the adoption of PGx testing by US physicians suggests that this trend may start changing for the better. Acquiring more knowledge of PGx tests and their clinical significance during graduate and postgraduate education will enable physicians to make better use of the available and upcoming PGx diagnostics in clinical practice.
Comment on
-
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.Clin Pharmacol Ther. 2012 Mar;91(3):450-8. doi: 10.1038/clpt.2011.306. Epub 2012 Jan 25. Clin Pharmacol Ther. 2012. PMID: 22278335
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
